AIIMS director Dr. Randeep Guleria on Monday warned for the indiscriminate use of steroids as well as treating mild symptoms of COVID-19 patients with CT scans and tests. Dr. According to Guleria, hospitals were seeing mild patients who consumed steroids, triggered virus replication and caused a drop in oxygen levels.
“We have to recognize that taking steroids at an early stage can lead to over-exacerbation of the virus. In many cases, mild cases are becoming severe, and patients are reporting severe pneumonia. Any steroids in the first five days of the disease Not a role. ” Guleria said.
He further stated that medicines like Remedisvir, Plasma Therapy, Tosilizumab are authorized for emergency use only as there are limited data on benefits. Also, its timing is very important when these drugs are administered.
The AIIMS director also cautioned that CT scans and biomarker tests were not required in mild COVID-19 cases. He said that a CT scan was equivalent to 300–400 chest x-rays and if the scan was overused, there could be a potential risk of cancer. “If you are home with mild illness and oxygen saturation is good, then there is no point in doing a CT scan,” he said.
Dr. Randeep Guleria is a member of the National Task Force on COVID-19 constituted by the Central Government. According to him, for moderate illness, only three specific treatments are effective.
“The first is oxygen therapy; the second is the role of steroids when the disease is moderate and oxygen saturation is low. The third is anticoagulant because we know that COVID-19 pneumonia is slightly different from viral pneumonia and causes blood clots. Promotes. Dr. Guleria said, “Blood clots can form in the lungs due to a drop in blood saturation. Again, in mild disease, anticoagulants have no role. “
The Center has also issued guidelines on the management of COVID-19 with increasing infection in children under 18 years of age.
Original Article Read at www.dnaindia.com